Clinical Cancer Research Journal Issues Research Articles in April 1, 2021 Edition
April 01, 2021
April 01, 2021
PHILADELPHIA, Pennsylvania, April 1 -- Clinical Cancer Research, a journal from the American Association for Cancer Research that presents clinical and translational cancer research studies that bridge the laboratory and the clinic, published research articles, including the following topics, in its April 1, 2021 edition:
CCR Drug Updates:
* FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepato . . .
CCR Drug Updates:
* FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepato . . .
